<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02423330</url>
  </required_header>
  <id_info>
    <org_study_id>14072904</org_study_id>
    <nct_id>NCT02423330</nct_id>
  </id_info>
  <brief_title>A Prospective Evaluation of the Strattice-LIFT to Treat Anal Fistula</brief_title>
  <official_title>A Prospective Evaluation of the Strattice-LIFT to Treat Anal Fistula</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rush University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rush University Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This clinical trial will evaluate the safety and efficacy of the Strattice-LIFT procedure to&#xD;
      treat anal fistulas.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The treatment of anal fistulas remains a challenging clinical problem. Fistulotomy is highly&#xD;
      effective, but carries a significant risk of postoperative incontinence. A variety of&#xD;
      surgical procedures that do not divide the sphincter muscle may be offered to patients,&#xD;
      however none of them are as effective as fistulotomy.&#xD;
&#xD;
      The LIFT (ligation of intersphincteric fistula tract) procedure is a newer option for the&#xD;
      treatment of transsphincteric fistulas. Initial results have been promising. However, some&#xD;
      fistulas recur after the LIFT procedure because the divided ends of the fistula tract&#xD;
      recanalize. Insertion of a barrier into the intersphincteric space may prevent this process.&#xD;
      Strattice is acellular porcine dermis, will be used for this purpose.&#xD;
&#xD;
      This prospective trial will evaluate the safety and efficacy of the Strattice-LIFT procedure&#xD;
      for the treatment of transsphincteric anal fistulas.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Study terminated by sponsor&#xD;
  </why_stopped>
  <start_date type="Actual">September 2014</start_date>
  <completion_date type="Actual">August 2017</completion_date>
  <primary_completion_date type="Actual">August 2017</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Healing of the anal fistula</measure>
    <time_frame>6 months</time_frame>
    <description>Healing is defined as the combination of patient reported lack of drainage and surgeon reported closure of the external opening</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Healing of the anal fistula</measure>
    <time_frame>1 year</time_frame>
    <description>Healing is defined as the combination of patient reported lack of drainage and surgeon reported closure of the external opening</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Pain</measure>
    <time_frame>1 year</time_frame>
    <description>Postoperative pain will be assessed at each postoperative visit with a visual analog scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>1 year</time_frame>
    <description>Postoperative complications such as infection/abscess, bleeding, urinary retention, new fistula, constipation, or fecal incontinence</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">1</enrollment>
  <condition>Anal Fistula</condition>
  <condition>Rectal Fistula</condition>
  <condition>Fistula in Ano</condition>
  <condition>Transsphincteric Fistula</condition>
  <arm_group>
    <arm_group_label>Strattice-LIFT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Strattice-LIFT</intervention_name>
    <description>Patients undergoing surgery for transsphincteric anal fistulas will undergo the Strattice-LIFT procedure. A standard LIFT procedure will be performed with the addition of Strattice placed into the intersphincteric space.</description>
    <arm_group_label>Strattice-LIFT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Subject is 22 years of age or older&#xD;
&#xD;
          2. Subject is willing to comply with study related procedures&#xD;
&#xD;
          3. Subject is not pregnant&#xD;
&#xD;
          4. Subject has a transsphincteric fistula&#xD;
&#xD;
          5. Subject is medically fit to undergo LIFT&#xD;
&#xD;
          6. Subject has a draining seton for a minimum of 6 weeks&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Crohn's disease&#xD;
&#xD;
          2. Pelvic radiation treatment&#xD;
&#xD;
          3. Known or suspected HIV/AIDS&#xD;
&#xD;
          4. Known sensitivity to pork products&#xD;
&#xD;
          5. Abscess or fistula etiology other than cryptoglandular&#xD;
&#xD;
          6. Abdominal malignancies&#xD;
&#xD;
          7. Patients with &lt;1 year life expectancy&#xD;
&#xD;
          8. History of smoking&#xD;
&#xD;
          9. Known anorectal dysfunction (fecal incontinence)&#xD;
&#xD;
         10. Chronic use of steroids or other agents which may affect wound healing&#xD;
&#xD;
         11. ASA â‰¥ 2&#xD;
&#xD;
         12. Unable to consent to study&#xD;
&#xD;
         13. Unable to complete 1 year follow up&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Rush University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>April 17, 2015</study_first_submitted>
  <study_first_submitted_qc>April 17, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 22, 2015</study_first_posted>
  <last_update_submitted>September 7, 2021</last_update_submitted>
  <last_update_submitted_qc>September 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Fistula</mesh_term>
    <mesh_term>Fistula</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

